Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey

Abstract

AbstractBackgroundThe role of nasal potential difference (NPD) measurement as a diagnostic test for cystic fibrosis (CF) is a subject of global controversy because of the lack of validation studies, clear reference values, and standardized protocols for diagnostic NPD.MethodsTo determine diagnostic NPD frequency, protocols, interpretation, and rater agreement, we surveyed the 18 NPD centres of the European Cystic Fibrosis Society Diagnostic Network Working Group.ResultsFifteen centres reported performing 373 diagnostic NPDs in 2012. Most use the CFF–TDN–SOP (67%) and the chloride-free+isoproterenol response of the side with the largest response (47%) as diagnostic criteria and use centre-specific reference ranges. Rater agreement for five NPD tracings – in general – was good, but poor in tracings with different responses between the two nostrils.ConclusionsNPD is frequently used as a diagnostic and research tool for CF. Performance is highly standardized, centre-specific reference ranges are established, and rater agreement – in general – is good. Centre-independent diagnostic criteria and reference ranges must be defined by multicentre validation studies to improve standardized interpretation for diagnostic use